Progression of Early Subclinical Atherosclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Agustin Mocoroa, MD
Banco Santander
Study Chair - Ana Dopazo, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Antonio I Fernández Ortiz, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Director - Beatriz Lopez Melgar, MD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Borja Ibañez, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Ginés Sanz, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Jose Luis Peñalvo, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Jose María Ordovás, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Leticia Fernández Friera, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Luis Jesús Jiménez Borreguero, MD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Martín Laclaustra, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Study Chair - Valentín Fuster, PhD
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ciudad Financiera del Grupo Santander
Boadilla del Monte, Madrid, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jun 2010
- Primary completion
- 30 Jun 2030
- Completion
- 30 Jun 2030
- Last update posted
- 29 Apr 2021
- Registered enrollment
- 4,184
- Registry id
- NCT01410318
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.